1. Genetically Predicted Glucose-Dependent Insulinotropic Polypeptide (GIP) Levels and Cardiovascular Disease Risk Are Driven by Distinct Causal Variants in the GIPR Region
    Nicholas Bowker et al, 2021, Diabetes CrossRef
  2. Heparin Oligosaccharides as Vasoactive Intestinal Peptide Inhibitors via their Binding Process Characterization
    Meixin Li et al, 2024, Current Protein & Peptide Science CrossRef
  3. Glucagon-Like Peptide 1 Attenuates Lipotoxicity-Induced Islet Dysfunction in ApoE–/– Mice


    Fuqiang Liu et al, 2020, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy CrossRef
  4. Novel Therapeutical Approaches to Managing Atherosclerotic Risk
    Rosaria Vincenza Giglio et al, 2021, International Journal of Molecular Sciences CrossRef
  5. Protective Effect of High-Intensity Interval Training (HIIT) and Moderate-Intensity Continuous Training (MICT) against Vascular Dysfunction in Hyperglycemic Rats
    Nurul Paramita et al, 2022, Journal of Nutrition and Metabolism CrossRef
  6. Physiological Functions of Polyphenols via Gastrointestinal Signaling
    Yoko Yamashita, 2022, Nippon Eiyo Shokuryo Gakkaishi CrossRef
  7. Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide
    Fatemeh Taktaz et al, 2024, Cardiovascular Diabetology CrossRef
  8. Cardiovascular effects of glucagon-like peptide 1 receptor agonists: from mechanistic studies in humans to clinical outcomes
    Valerie D Heuvelman et al, 2020, Cardiovascular Research CrossRef
  9. Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy
    Jonathan Goldney et al, 2023, Diabetologia CrossRef
  10. Aging and Redox Pathways in Diabetes
    Carlos S. Botero Suarez et al, 2022, Redox Signaling and Biomarkers in Ageing CrossRef
  11. Oral and intravenous glucose administration elicit opposing microvascular blood flow responses in skeletal muscle of healthy people: role of incretins
    Katherine M. Roberts‐Thomson et al, 2022, The Journal of Physiology CrossRef
  12. Amelioration of Endothelial Dysfunction in Diabetes: Role of Takeda G Protein–Coupled Receptor 5
    Zhengyao Cai et al, 2021, Frontiers in Pharmacology CrossRef
  13. GIP as a Potential Therapeutic Target for Atherosclerotic Cardiovascular Disease–A Systematic Review
    Yusaku Mori et al, 2020, International Journal of Molecular Sciences CrossRef
  14. The Role of Pancreatic Alpha Cells and Endothelial Cells in the Reduction of Oxidative Stress in Pseudoislets
    Fredrik C. Wieland et al, 2021, Frontiers in Bioengineering and Biotechnology CrossRef
  15. Black soybean seed coat polyphenols promote nitric oxide production in the aorta through glucagon-like peptide-1 secretion from the intestinal cells
    Chiaki Domae et al, 2019, Food & Function CrossRef
  16. Gut Molecules in Cardiometabolic Diseases: The Mechanisms behind the Story
    Andreea-Ioana Inceu et al, 2023, International Journal of Molecular Sciences CrossRef
  17. TGR5 signalling in heart and brain injuries: focus on metabolic and ischaemic mechanisms
    Nan Xu et al, 2024, Neurobiology of Disease CrossRef
  18. Why the endothelium? The endothelium as a target to reduce diabetes-associated vascular disease
    Chris R. Triggle et al, 2020, Canadian Journal of Physiology and Pharmacology CrossRef
  19. Glucose-Dependent Insulinotropic Polypeptide Suppresses Peripheral Arterial Remodeling in Male Mice
    Yusaku Mori et al, 2018, Endocrinology CrossRef
  20. Usefulness of circulating EPAC1 as biomarkers of therapeutic response to GLP-1 receptor agonists
    Cristina Hernández et al, 2022, Acta Diabetologica CrossRef
  21. The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update
    Michael A. Nauck et al, 2021, Diabetes, Obesity and Metabolism CrossRef
  22. Evaluation of drug interactions of saxagliptin with sildenafil in healthy volunteers
    Rania Y. Mansour et al, 2022, European Journal of Clinical Pharmacology CrossRef
  23. Antiatherogenic effects of liraglutide in hyperglycemic apolipoprotein E-null mice via AMP-activated protein kinase-independent mechanisms
    Masakazu Koshibu et al, 2019, American Journal of Physiology-Endocrinology and Metabolism CrossRef